NCT06033846View on ClinicalTrials.gov

Efficacy and Safety of Adjunctive Minocycline in the Treatment of Autoimmune Encephalitis

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 1, 2023

Primary Completion Date

June 3, 2024

Study Completion Date

July 16, 2025

Conditions
Autoimmune Encephalitis
Interventions
DRUG

Minocycline

treatment with minocycline combined with first-line drugs for autoimmune encephalitis

Trial Locations (1)

Unknown

Xijing Hospital, Xi'an

All Listed Sponsors
lead

Xijing Hospital

OTHER

NCT06033846 - Efficacy and Safety of Adjunctive Minocycline in the Treatment of Autoimmune Encephalitis | Biotech Hunter | Biotech Hunter